AMAT
32
-5
GE
57
-5
EIX
42
2
COF
58
-2
ORCL
46
-4
ROP
62
-3
STT
56
-8
MU
48
-4
CAT
43
-5
FLR
40
-8
LB
39
-18
IR
55
-3
LUV
52
-4
MCO
64
-4
GWW
51
-9
MHK
40
-6
NWL
41
-2
M
21
-4
XRX
28
-3
FIS
72
-5
AMAT
32
-5
GE
57
-5
EIX
42
2
COF
58
-2
ORCL
46
-4
ROP
62
-3
STT
56
-8
MU
48
-4
CAT
43
-5
FLR
40
-8
LB
39
-18
IR
55
-3
LUV
52
-4
MCO
64
-4
GWW
51
-9
MHK
40
-6
NWL
41
-2
M
21
-4
XRX
28
-3
FIS
72
-5
Financhill
Back

Arcturus Therapeutics Holdings Stock Predictions

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19

ARCT
Arcturus Therapeutics Holdings

Last Price:
$11.59
Seasonality Move:
30.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Arcturus Therapeutics Holdings Stock Forecast

  • Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 11.1% based on the past 11 years of stock performance.
  • Arcturus Therapeutics Holdings has risen higher in 3 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 27.27%
  • Is Arcturus Therapeutics Holdings Stock Undervalued?
    The current Arcturus Therapeutics Holdings [ARCT] share price is $11.58. The Score for ARCT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Arcturus Therapeutics Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 11.1% based on the past 11 years of stock performance.

Arcturus Therapeutics Holdings Stock Rating

Sell
19
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings overpriced?

  • Arcturus Therapeutics Holdings has risen higher in 3 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 27.27%

Arcturus Therapeutics Holdings Stock Price History

Is ARCT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com

52-Week Data

52-Week High:
45.00
52-Week Low:
11.39

Prediction Charts

Market Cap:
314M
Price in USD:
11.58
Volume:
311K
Beta:
2.51

Technical Analysis

SMA50:
15.63
SMA100:
16.64
SMA200:
19.66
52-Wk Change:
-65.71%

Stock Predictions

  • Is Arcturus Therapeutics Holdings stock public?
    Yes, Arcturus Therapeutics Holdings is a publicly traded company.
  • What is the Arcturus Therapeutics Holdings stock quote today?
    The Arcturus Therapeutics Holdings stock price is 11.58 USD today.
  • How to buy Arcturus Therapeutics Holdings stock online?
    You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 14.42 13.21 14.78 12.75
Mar-12 13.54 14.26 14.50 13.39
Mar-13 14.15 13.90 14.56 13.57
Mar-14 14.02 14.08 14.29 13.38
Mar-17 14.08 14.16 14.56 13.81
Mar-18 13.92 13.73 14.37 13.39
Mar-19 13.76 13.40 13.88 13.18
Mar-20 13.22 12.84 13.54 12.65
Mar-21 12.59 12.88 12.93 11.60
Mar-24 12.95 13.27 13.31 12.85
Mar-25 13.26 12.77 13.41 12.65
Mar-26 12.64 11.95 12.83 11.71
Mar-27 12.04 12.00 12.22 11.75
Mar-28 12.00 11.58 12.10 11.39

Arcturus Therapeutics Holdings Earnings

Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Arcturus Therapeutics Holdings Forecast Revenue Growth

Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.14 per share, a decrease this year of $2.40 per share, and an increase next year of $0.98 per share.

* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.